1. Development of 1-(4-(Substituted)piperazin-1-yl)-2-((2-((4-methoxybenzyl)thio)pyrimidin-4-yl)oxy)ethanones That Target Poly (ADP-Ribose) Polymerase in Human Breast Cancer Cells
   Suresha N. Deveshegowda et al, 2022, Molecules CrossRef
2. On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
   Fadia Boudghene-Stambouli et al, 2022, Cancers CrossRef
3. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways
   Mehrdad Hashemi et al, 2023, European Journal of Pharmacology CrossRef
4. A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention
   Yaping Yan et al, 2024, International Journal of Biological Macromolecules CrossRef
5. Recent advancements in small interfering RNA (siRNA) based therapeutic approach on breast cancer
   Kathirvel Kalaimani et al, 2024, European Journal of Pharmacology CrossRef
6. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer
   Ling Ou et al, 2024, Heliyon CrossRef
7. Anti-liver cancer therapeutic targets and safety of usenamine A in experimental liver cancer
   Xiaoqiong He et al, 2024 CrossRef